Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.407ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.407EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.407EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.407ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.407ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AA.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AA.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AA.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AA.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.47ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.47ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.47EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.47EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.182EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.182ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.182ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.182EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.182EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.182ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.218EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.218ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.218ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.218EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.218EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.218ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.218ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.12.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.12.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.12.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.12.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used